Because the brain lacks a true lymphatic system, it is unclear how peripheral lymphocytes recognize foreign antigens present in the central nervous system. This report demonstrates that the choroid plexus, which constitutes the blood-cerebrospinal fluid barrier, is able to present foreign antigen to, and stimulate the proliferation of, peripheral helper T lymphocytes through an Ia-dependent, major histocompatibility complex-restricted mechanism. Furthermore, in vivo, choroid plexus epithelial cells have access to, and are capable of taking up, virus-sized particles injected elsewhere into the cerebrospinal fluid. Thus these data suggest that the bloodcerebrospinal fluid barrier may play a role in immunological communication between the central nervous system and periphery, a function relevant to the initiation of immunological responses to central nervous system infections and autoimmune processes and for the surveillance of tumor cells in the cerebrospinal fluid.
During disease states, the brain contains immunoglobulinproducing plasma cells and T lymphocytes (1, 2) . These cells, which are normally present in only small numbers, appear to enter the central nervous system (CNS) from the systemic circulation (3) . Surprisingly, little is known about how this immune process is initiated; particularly, how, at a time when lymphocytes are largely absent from the brain, foreign antigens in the CNS are recognized and processed for presentation to helper T cells (a necessary step for the initiation of most types of cellular-and humoral-mediated immunity). In the periphery, interaction among lymphocytes, antigen-presenting cells (e.g., macrophages), and antigen is facilitated by a highly developed lymphatic drainage system. However, the brain parenchyma, itself, contains no comparable lymph system and, furthermore, is largely isolated from the systemic circulation by the blood-brain and bloodcerebrospinal fluid (CSF) barriers. Even with the help of endogenous CNS antigen-presenting cells, such as microglia or astrocytes (4) (5) (6) (7) (8) , it is unclear how antigens present in the CNS can interact with unstimulated lymphocytes located in the periphery.
Prior studies have suggested that foreign substances present in brain extracellular fluid can move by bulk flow into the CSF (9, 10) , which itselfundergoes a slow movement through the lateral, third, and fourth ventricles, into the cisterna magna. It occurred to us that the choroid plexuses (which also contribute to CSF formation) might be well-suited to detect foreign antigens present in the CSF and to communicate this information to the periphery. Choroid plexus tissue not only comes in close contact with CSF in the ventricular cavities but also is strategically present at the narrow foramina through which the CSF passes from lateral to third ventricles and from fourth ventricle to cisterna magna. In addition, the tightly joined choroid epithelial cells (constituting the blood-CSF barrier) form an interface between CSF and periphery, since their apical side faces the CSF and their basal side, facing fenestrated capillaries, has potential access to peripheral blood cells. The present report investigates the possible immune functions of the choroid plexus, in particular, its potential access to and uptake of foreign antigens, and its ability to present foreign antigens to peripheral lymphocytes.
MATERIALS AND METHODS
Choroid plexus tissue consists of numerous capillary and arteriolar loops containing fenestrated endothelium and smooth muscle cells covered with a single layer of cuboidal secretory epithelium (11) . Present on the CSF-facing surface of the epithelium are occasional stellate-shaped epiplexus cells. For antigen presentation experiments, choroid epithelium was purified by modifications of prior techniques (12, 13) . Briefly, intact lateral, third, and fourth ventricular choroids from 4-to 6-week-old BALB/c mice were dissected in Dulbecco's modified Eagle's medium (DMEM) and meticulously cleaned of any adhering meninges or brain under a high-power dissecting scope. Pooled choroid plexuses were further washed (for three 10-min periods) in DMEM by gently tumbling (90 rpm) in an apparatus that allowed suspended cells to be separated and removed from intact tissue. Subsequently, tissue was tumbled in calcium-free artificial CSF (12) containing 0.05% trypsin (Sigma T 0511) and 0.015 mM EDTA. Every 15 min for 4 hr, choroids were gently triturated and fractions containing suspended cells were separated from intact tissue; in this manner, a large peak of highly enriched epithelial cells was obtained (usually fractions [3] [4] [5] [6] prior to the onset of dissociation of the choroid plexus stroma (usually fractions [10] [11] [12] [13] [14] [15] . Cells from pooled fractions [3] [4] [5] [6] were filtered through 150-,um Nitex mesh to remove any cell aggregates and then plated in DMEM with 5% (vol/vol) fetal bovine serum in tissue culture dishes. After 4 hr, epithelial cells, which do not adhere, were removed by gentle swirling, leaving behind a small number of adherent nonepithelial cells. Using this procedure, %105 epithelial cells were obtained per mouse.
For measuring T-cell proliferation by thymidine incorporation in antigen-presentation experiments, it was necessary to prevent cell division of the antigen-presenting cell. Although choroid epithelium from postnatal animals does not normally proliferate in culture, isolated epithelial cells were nonetheless routinely irradiated with 2300 rads (1 rad = 0.01 Gy), a dose known to prevent proliferation of other types of antigen-presenting cells (6, 14 (Fig. 1) were carried out in seven experiments and aggregation was a consistent finding. Antigen dose-response experiments were replicated three times and the data shown ( Fig. 2A) are typical. Controls showing antigen presentation to 03 by BALB/c spleen cells were carried out three times using conditions identical to those for choroid-03 experiments. For those experiments (done twice), which used antibody directed against Ta, antigen (100 Ag/ml) and antibody were added at the time of coculture.
Antibody was purified by (NH4)2SO4 precipitation from culture supernatants prepared from hybridoma 34-5-3S (15), whereas, for antibody from hybridoma 144-4S (16) , ascites fluid (Cedarlane Laboratories, Hornby, ON) was used.
For histological identification of cell type (carried out for most experiments), parallel cultures in 15-mm wells were plated and incubated for 48 hr. Four hours prior to fixation, cells were incubated with fluorescent acetylated low density lipoprotein (DiI-Ac-LDL; Biomedical Technologies, Stoughton, MA; 1:30 dilution), a marker taken up by macrophages and endothelial cells but minimally taken up by choroid epithelium. After fixation in cold 1% paraformaldehyde, wells were washed three times with isotonic phosphatebuffered saline (PBS) and once with 4% (vol/vol) goat serum and incubated overnight at 40C with rabbit antibody (diluted 1:150) to the a form of Na,K-ATPase or with mouse monoclonal antibody (diluted 1:300) to dopamine-and cAMPregulated phosphoprotein (DARPP-32). (Antibodies were diluted in 0.3% Triton X-100 in PBS.) After five washes with PBS, cultures were incubated for 1 hr at 22°C with a fluorescein-conjugated second antibody (Cappel Laboratories, 1:100 dilution), washed, and viewed by epifluorescence with an inverted microscope. In some experiments, after fixation, cells were harvested by scraping, transferred to centrifuge tubes, and then immunostained in suspension, as described below for particle uptake experiments.
For histochemical demonstration of Ta expression in choroid organ culture, minced pieces of intact BALB/c choroid plexus were cultured in DMEM containing recombinant mouse y-interferon (IFN-y) (Genentech) at 1000 units/ml, 1 AM indomethacin, and Escherichia coli lipopolysaccharide (Difco 3123-25) at 10 ,ug/ml, all added initially and again at 24 hr. (IFN-y or lipopolysaccharide, alone, caused similar though less intense Ia staining. In the absence of either there was no Ta staining.) After 42 hr of culture, unfixed tissue was transferred to centrifuge tubes, washed, and stained overnight at 4°C with 34-5-3S (diluted 1:2), followed by fluorescein-conjugated second antibody (Cappel Laboratories, diluted 1:50). Subsequently, after washing and fixation in 1% paraformaldehyde, tissue was stained (to identify epithelial cells) overnight at 4°C with rabbit antibody to Na,K-ATPase (diluted 1:150), followed by rhodamine-conjugated second 
RESULTS AND DISCUSSION
We first wished to determine the ability of the choroid plexus to initiate an immune response. For this purpose, a highly enriched suspension of choroid epithelial cells was prepared from BALB/c mice. By a variety of criteria, these cells were free of contaminating macrophages, endothelial cells, and astroglia (see below). The purified epithelial cells were irradiated to prevent cell division and then co-cultured in microtiter wells, or in slide wells, with the antigen-specific helper T-cell clone 03 in the absence or presence of the antigen chicken ovalbumin. The co-cultures were observed over a 48-or 72-hr period for morphological changes associated with 03 lymphocyte activation and for [3H]thymidine incorporation indicative of 03 cell proliferation.
Co-cultures of lymphocytes and choroid plexus cells incubated in the presence of ovalbumin at 100 gg/ml developed numerous activated centers, consisting of clusters of mixed lymphocytes and epithelial cells (Fig. la) . In the absence of antigen, cells remained largely dispersed (Fig. lb) . Likewise, lymphocytes in the presence of antigen alone, or choroid plexus cells in the presence of antigen alone, failed to show the formation of activated centers. The activated centers observed were quite similar in appearance to those seen when peripheral spleen cell-derived macrophages were co-cultured with lymphocytes in the presence of antigen (Fig. ic) .
Although associated with lymphocyte activation, aggregate formation can also involve non-antigen-specific, nongenetically restricted factors (17) . Therefore, to supply direct evidence for lymphocyte proliferation, [3H]thymidine incorporation was measured. Fig. 2A demonstrates a marked increase in isotope incorporation when choroid cells and lymphocytes were co-cultured in the presence of various concentrations of ovalbumin. The maximal response to antigen resulted in a >100-fold increase in incorporation, and the dose of ovalbumin causing 50% maximal activation of proliferation (EC50) was about 5 ug/ml. Under identical conditions, 03 lymphocytes co-cultured with irradiated BALB/c spleen cells showed a similar maximal increase in incorporation with an EC50 of 0.5 JUg/ml. In the absence of either choroid epithelial cells or T cells, addition of ovalbumin caused no significant stimulation of thymidine incorporation ( Fig. 2A) . Also, in an experiment in which bovine serum albumin was used as antigen instead of chicken ovalbumin, stimulation of 03 proliferation was not seen.
In a choroid plexus cell dose-response experiment, in which T-cell number (5 x 104 cells) and antigen dose (300 gg/ml) were held constant, we found that choroid plexus cells were highly efficient in presenting antigen, fewer than 103 cells producing a detectable proliferative response. This low presenting-cell/T-cell ratio of 1:50 makes it highly unlikely that the proliferative response observed was due to a nonspecific effect related to a high cell density created (1989) leaving behind the connective tissue and vascular components that are the largest potential source of contaminating macrophages.
(ii) Prior to use, the isolated cells were further purified by an adherence separation in which choroid epithelial cells, which do not adhere to tissue culture plastic, were separated from contaminating macrophages and endothelial cells, which do adhere. This resulted in a histologically homogenous population of cells >99.9% positive for the choroid epithelial cell markers described below. (iii) In histochemical studies, <0.1% of the purified epithelial cells stained with DiI-Ac-LDL, a marker that is avidly taken up by macrophages and vascular endothelium (18) . More importantly, as shown in Fig. ld, no DiI-Ac-LDL-positive cells were observed in the aggregates present in the choroid-03 co-cultures, in marked contrast to aggregates present in spleen cell-lymphocyte co-cultures, which showed numerous DiI-Ac-LDL-labeled macrophages (Fig. if) . (iv) Antibody to membrane attack complex type 1 (MAC-1), a surface marker directed against an epitope present on murine macrophages, also failed to stain any choroid epithelial cells, in contrast to positive MAC-1 staining that we obtained with spleen-derived macrophages. (As with choroid plexus cells, the 03 line itself was free of contaminating macrophages, as indicated by negative MAC-1 and DiI-Ac-LDL staining.) Finally, in other immunohistochemical studies, antibody to glial fibrillary acidic protein (an astroglial marker) did not label any cells present in choroid-03 activated centers.
Utilizing a different approach, and to provide additional evidence for cell purity, we employed two cell markers to specifically label choroid epithelial cells. (i) Polyclonal antibody specific for the a form of Na,K-ATPase, an enzyme present in very high concentration in choroid plexus and other transporting epithelium (11, 19) , brightly labeled numerous epithelial cells present in the choroid-03 aggregates (Fig. ig) . At the antibody dilution used, all other cells in the choroid, as well as macrophages and endothelial cells, stained only very faintly since they contained much lower concentrations of Na,K-ATPase. Also, the antibody only faintly labeled cells present in spleen cell-03 aggregates (Fig.   ii). (ii) In other experiments (Fig. 3a) , epithelial cells labeled brightly with monoclonal antibodies to DARPP-32, a protein present in the choroid plexus but not detected in macrophages or endothelial cells (13, 20) . Likewise, in co-culture studies, antibodies to DARPP-32 labeled cells in choroid-03 aggregates but did not label cells in spleen cell-03 aggregates (data not shown).
In the periphery, antigen-presenting cells, such as macrophages, need to express class II histocompatibility glycoproteins (Ia antigen) on their surface to present antigen to T cells. Therefore, to determine if Ia might be involved in choroidstimulated activation of T cells, we attempted to block choroid-stimulated T-cell proliferation by adding a monoclonal antibody (34-5-3S) that recognizes mouse I-Ad (15) to the co-cultures. Fig. 2B shows that increasing the amounts of anti-Ia resulted in a progressive loss of choroid-stimulated T-cell activation. (In another experiment, similar amounts of 34-5-3S were required to inhibit antigen presentation by spleen cells.) This experiment, indicating the presence of Ia, was consistent with an immunohistochemical study of IFN- t-stimulated choroid plexus in organ culture (Fig. 4) , in which Ia antigen staining was observed on a number of (but not all) epithelial cells that had been identified by their co-labeling with Na,K-ATPase. In the absence of IFN-y, little staining was seen. [Presumably, in situ, stimulation of Ia expression on epithelium would occur through interaction with T cells passing through the choroid or as a result of contact with virus particles, independent of IFN-y, as has been demonstrated for astrocytes (8) . ] Consistent with major histocompatibility complex (MHC) restriction requirements, monoclonal antibody (14-4-4S), which recognizes I-Ed (16) , failed to block proliferation of 03 cells by choroid plexus cells (Table 1) . Additional evidence that the antigen-presenting capability of choroid plexus cells is MHC-restricted was obtained by using another Tlymphocyte clone, BC4, reactive to bovine insulin and of MHC type H-2b (21) . When choroid cells from BALB/c (H02d) were co-cultured with BC4 T cells in the presence of antigen, no stimulation occurred, in contrast to the stimulation that occurred when BC4 was co-cultured with macrophage-containing spleen cells from a B10 (H-2b) mouse (Table   1) . Such results, plus the above data, strongly suggest that choroid plexus cells are capable of specific activation of peripheral T cells in vitro.
We next wished to determine whether, in vivo, choroid plexus cells have access to particulate antigens entering the CSF at some distance from the choroid and whether such antigens could approach the choroid and be taken up by the epithelial cells. Accordingly, we injected, into the lateral ventricle of a rabbit, virus-sized (100 nm in diameter) fluorescent noncarboxylated polystyrene microspheres. Eighteen hours later, the fourth ventricular choroid was removed and washed extensively, and the epithelium was isolated. cells were labeled with antibody to DARPP-32 or to Na,KATPase (to identify the choroid epithelium) (Fig. 3 a and c) and then examined for the presence of fluorescent microspheres. Fig. 3b shows that many cells [47 ± 6% (mean + SEM) of all DARPP-32-positive epithelial cells] showed the presence of microspheres. In some cells (Fig. 3d) , labeling was so intense that the outline of the cell nucleus could be visualized, strongly suggesting an intracellular localization of the microspheres. These results indicate that, in vivo, the choroid epithelium has access to particulate material introduced elsewhere into the CSF and, despite the large rate of fluid production from its apical surface, the epithelium is capable of taking up this material intracellularly. Choroid epithelium is also known to be capable of absorbing soluble proteins from the CSF (22) , and other studies have shown that ventricular ependymal cells, from which choroid epithelium is derived, have specific receptors for several viruses (23) .
In vivo, it is known that peripheral T cells can pe w. -rate the fenestrated choroid capillaries, thereby gaining po-tential access to the choroid epithelium (24, 25) . Of inter-est. these epithelial cells also contain large concentrations cf ?c eceptors on their surface (26) . Given the results of our stu(ies, it is conceivable that in vivo the choroid plexus cc old sake up antigens from the CSF and present them to peripheral -i cells, thereby functioning as a type of immunological commu-nications link between the CSF and blood. Such activated lymphocytes might function peripherally or, at so.nme later time, enter the CNS through the cerebral vasculatlre. (Such activation of T cells could be an important factor-gye .rning the ability of a lymphocyte to cross the blood-born a ,arrier, thereby providing a mechanism by which the Inrain can restrict lymphocyte traffic only to "relevant" T c+AHs.)
The present results have implications for the initiation of immunological responses in CNS infections and autoimmune processes and for the surveillance of tumor cells in the CSF. Because substances present in brain parenchyma are known to enter the CSF, the choroid has potential access to antigens present not only exclusively in the CSF but also arising from elsewhere in the CNS outside the ventricular system (including, e.g., antigens coming from brain parenchymal infections). Our findings also have implications for the recognition of certain systemic viruses, parasites, and other antigens (e.g., lymphocytic choriomeningitis virus and trypanosomes) that may enter the CSF through, or proliferate within, the choroid plexus (27) (28) (29) (30) (31, 32) , or communication through the endothelial cells of the blood-brain barrier (33, 34) or through
